These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16566635)

  • 1. Ziprasidone-induced acute dystonic reactions in patients with bipolar disorder.
    Weinstein SK; Adler CM; Strakowski SM
    J Clin Psychiatry; 2006 Feb; 67(2):327-8. PubMed ID: 16566635
    [No Abstract]   [Full Text] [Related]  

  • 2. Tardive dyskinesia and ziprasidone.
    Rosenquist KJ; Walker SS; Ghaemi SN
    Am J Psychiatry; 2002 Aug; 159(8):1436. PubMed ID: 12153846
    [No Abstract]   [Full Text] [Related]  

  • 3. Tardive dystonia associated with ziprasidone.
    Papapetropoulos S; Wheeler S; Singer C
    Am J Psychiatry; 2005 Nov; 162(11):2191. PubMed ID: 16263868
    [No Abstract]   [Full Text] [Related]  

  • 4. Ziprasidone-induced acute dystonia.
    Mason MN; Johnson CE; Piasecki M
    Am J Psychiatry; 2005 Mar; 162(3):625-6. PubMed ID: 15741487
    [No Abstract]   [Full Text] [Related]  

  • 5. Atypical antipsychotic drug-induced acute laryngeal dystonia: 2 case reports.
    Mellacheruvu S; Norton JW; Schweinfurth J
    J Clin Psychopharmacol; 2007 Apr; 27(2):206-7. PubMed ID: 17414248
    [No Abstract]   [Full Text] [Related]  

  • 6. Ziprasidone-induced tardive dyskinesia.
    Mendhekar DN
    Can J Psychiatry; 2005 Aug; 50(9):567-8. PubMed ID: 16262114
    [No Abstract]   [Full Text] [Related]  

  • 7. Tardive dyskinesia in 2 patients treated with ziprasidone.
    Ananth J; Burgoyne KS; Niz D; Smith M
    J Psychiatry Neurosci; 2004 Nov; 29(6):467-9. PubMed ID: 15644988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ziprasidone induction of hypomania in depression?
    Davis R; Risch SC
    Am J Psychiatry; 2002 Apr; 159(4):673-4. PubMed ID: 11925314
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute pisa syndrome and pharnygolaryngeal dystonia due to ziprasidone.
    Duggal HS
    J Neuropsychiatry Clin Neurosci; 2008; 20(1):108-9. PubMed ID: 18305296
    [No Abstract]   [Full Text] [Related]  

  • 10. Ziprasidone-induced tardive laryngeal dystonia: a case report.
    Tsai CS; Lee Y; Chang YY; Lin PY
    Gen Hosp Psychiatry; 2008; 30(3):277-9. PubMed ID: 18433661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole-induced movement disorder.
    Zacher JL; Hatchett AD
    Am J Psychiatry; 2006 Jan; 163(1):160-1. PubMed ID: 16390909
    [No Abstract]   [Full Text] [Related]  

  • 12. Sudden akathisia after a ziprasidone dose reduction.
    Oral ET; Altinbas K; Demirkiran S
    Am J Psychiatry; 2006 Mar; 163(3):546. PubMed ID: 16513883
    [No Abstract]   [Full Text] [Related]  

  • 13. Mania associated with initiation of ziprasidone.
    Nolan BP; Schulte JJ
    J Clin Psychiatry; 2003 Mar; 64(3):336. PubMed ID: 12716277
    [No Abstract]   [Full Text] [Related]  

  • 14. High-dose ziprasidone-induced acute dystonia.
    Rosenfield PJ; Girgis RR; Gil R
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):546-7. PubMed ID: 17123682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomanic episodes after receiving ziprasidone: an unintended "on-off-on" course of treatment.
    Brieger P
    J Clin Psychiatry; 2004 Jan; 65(1):132-5. PubMed ID: 14744182
    [No Abstract]   [Full Text] [Related]  

  • 16. Ziprasidone induced tardive cervical dystonia.
    Kutlu A; Dündar S; Altun NS; Budak F
    Psychopharmacol Bull; 2009; 42(4):64-8. PubMed ID: 20581794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ziprasidone-induced angioedema: a case report.
    Mohan T; Bastiampillai T; Dhillon R
    J Clin Psychiatry; 2009 Jul; 70(7):1054. PubMed ID: 19653983
    [No Abstract]   [Full Text] [Related]  

  • 18. Ziprasidone-related tardive dyskinesia.
    Keck ME; Müller MB; Binder EB; Sonntag A; Holsboer F
    Am J Psychiatry; 2004 Jan; 161(1):175-6. PubMed ID: 14702272
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk for adverse events and discontinuation due to adverse events of ziprasidone monotherapy relative to placebo in the acute treatment of bipolar depression, mania, and schizophrenia.
    Gao K; Pappadopulos E; Karayal ON; Kolluri S; Calabrese JR
    J Clin Psychopharmacol; 2013 Jun; 33(3):425-31. PubMed ID: 23609405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ziprasidone-induced oculogyric crisis.
    Ramos AE; Shytle RD; Silver AA; Sanberg PR
    J Am Acad Child Adolesc Psychiatry; 2003 Sep; 42(9):1013-4. PubMed ID: 12964566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.